Ibrutinib Three Year Follow-up of Single-Agent and Combination Study Results in Chronic Lymphocytic Leukemia
- EMEA Innovative Medicine
- Ibrutinib Study: Results of Chronic Lymphocytic Leukemia Treatment
Ibrutinib Study: Results of Chronic Lymphocytic Leukemia Treatment
- X (Twitter)
Copy link